Research ArticleRadioimmunoimaging
In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET
Dinko E. González Trotter, Xiangjun Meng, Paul McQuade, Daniel Rubins, Michael Klimas, Zhizhen Zeng, Brett M. Connolly, Patricia J. Miller, Stacey S. O’Malley, Shu-An Lin, Krista L. Getty, Laurence Fayadat-Dilman, Linda Liang, Elisabet Wahlberg, Olof Widmark, Caroline Ekblad, Fredrik Y. Frejd, Eric D. Hostetler and Jeffrey L. Evelhoch
Journal of Nuclear Medicine November 2017, 58 (11) 1852-1857; DOI: https://doi.org/10.2967/jnumed.117.191718
Dinko E. González Trotter
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Xiangjun Meng
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Paul McQuade
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Daniel Rubins
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Michael Klimas
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Zhizhen Zeng
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Brett M. Connolly
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Patricia J. Miller
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Stacey S. O’Malley
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Shu-An Lin
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Krista L. Getty
2Screening and Protein Sciences Department, Merck & Co., Inc., West Point, Pennsylvania
Laurence Fayadat-Dilman
3Biologics Discovery, Merck & Co., Inc., Palo Alto, California
Linda Liang
3Biologics Discovery, Merck & Co., Inc., Palo Alto, California
Elisabet Wahlberg
4Affibody AB, Solna, Sweden; and
Olof Widmark
4Affibody AB, Solna, Sweden; and
Caroline Ekblad
4Affibody AB, Solna, Sweden; and
Fredrik Y. Frejd
4Affibody AB, Solna, Sweden; and
5Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Eric D. Hostetler
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Jeffrey L. Evelhoch
1Translational Biomarkers Department, Merck & Co., Inc., West Point, Pennsylvania
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 11
November 1, 2017
In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET
Dinko E. González Trotter, Xiangjun Meng, Paul McQuade, Daniel Rubins, Michael Klimas, Zhizhen Zeng, Brett M. Connolly, Patricia J. Miller, Stacey S. O’Malley, Shu-An Lin, Krista L. Getty, Laurence Fayadat-Dilman, Linda Liang, Elisabet Wahlberg, Olof Widmark, Caroline Ekblad, Fredrik Y. Frejd, Eric D. Hostetler, Jeffrey L. Evelhoch
Journal of Nuclear Medicine Nov 2017, 58 (11) 1852-1857; DOI: 10.2967/jnumed.117.191718
In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET
Dinko E. González Trotter, Xiangjun Meng, Paul McQuade, Daniel Rubins, Michael Klimas, Zhizhen Zeng, Brett M. Connolly, Patricia J. Miller, Stacey S. O’Malley, Shu-An Lin, Krista L. Getty, Laurence Fayadat-Dilman, Linda Liang, Elisabet Wahlberg, Olof Widmark, Caroline Ekblad, Fredrik Y. Frejd, Eric D. Hostetler, Jeffrey L. Evelhoch
Journal of Nuclear Medicine Nov 2017, 58 (11) 1852-1857; DOI: 10.2967/jnumed.117.191718
Jump to section
Related Articles
Cited By...
- Integrating Dynamic Network Analysis with AI for Enhanced Epitope Prediction in PD-L1:Affibody Interactions
- Predicting efficacy of immunotherapy in mice with triple negative breast cancer using a cholesterol PET radiotracer
- Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
- Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
- PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
- PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer
- The Immunoimaging Toolbox
- Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
- Reply: Optimizing Strategies for Immune Checkpoint Imaging with Immuno-PET in Preclinical Study
- In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment